Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery
NCT02283918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 467
Last updated 2015-10-05
Summary
The primary objective of the study is to develop MS patient-matched healthy population norms for the Multiple Sclerosis Cognition Assessment Battery (MS-COG) that are representative of the United States (US), France, and Italy.
Conditions
- Healthy
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Biogen
Eligibility
- Min Age
- 25 Years
- Max Age
- 58 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
- France
- Italy
Study Locations
More Related Trials
-
Metacognition Assessment in Patient With Multiple Sclerosis
NCT04240379 ·Status: COMPLETED
-
Bayer/Cognitive Assessments With Multiple Sclerosis Subjects
NCT00888277 ·Status: COMPLETED
-
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT00529581 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients
NCT01658384 ·Status: COMPLETED
-
Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
NCT01250665 ·Status: UNKNOWN
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012
NCT02579681 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension
NCT02383550 ·Status: COMPLETED
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
NCT01075880 ·Status: COMPLETED
-
MS PATHS Normative Sub-Study
NCT02996084 ·Status: COMPLETED
-
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
NCT01804647 ·Status: COMPLETED
-
Genes and Environment in Multiple Sclerosis
NCT01353547 ·Status: RECRUITING
-
The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis
NCT06599307 ·Status: RECRUITING ·Phase: PHASE2
-
Validation of DigiCog and Konectom Tools to Support Digitalized Clinical Assessment in Multiple Sclerosis
NCT04756700 ·Status: COMPLETED ·Phase: NA
-
Seoul National University Hospital Systemic Sclerosis Cohort
NCT02819947 ·Status: UNKNOWN
-
XO as a Screening Test of Cognitive Impairment in Multiple Sclerosis
NCT03999034 ·Status: UNKNOWN ·Phase: NA
-
Epidemiological Characteristics of COVID-19 in Patients With MS or NMO
NCT04355611 ·Status: COMPLETED
-
CorEvitas Multiple Sclerosis (MS) Registry
NCT03291756 ·Status: ENROLLING_BY_INVITATION
-
Fingolimod Real World Experience: the French Grand-Est Cohort
NCT02799199 ·Status: COMPLETED
-
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
NCT06283524 ·Status: COMPLETED
-
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
NCT07222618 ·Status: RECRUITING
-
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
NCT07280871 ·Status: NOT_YET_RECRUITING
-
Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis
NCT01207856 ·Status: COMPLETED ·Phase: NA
-
Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients
NCT04694534 ·Status: RECRUITING ·Phase: NA